Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system

Brain Research Reviews

Volumn 30, Issue 3, 1999, Pages 219-235

  Vizi, E S ^a   Lendvai, B ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Central nervous system; Nicotinic acetylcholine receptor; Non synaptic chemical communication; Synaptic chemical communication

Indexed keywords

1,1 DIMETHYL 4 PHENYLPIPERAZINIUM; CALCIUM CHANNEL; CHOLINESTERASE INHIBITOR; DOPAMINE; EPIBATIDINE; LOBELINE; MECAMYLAMINE; METHYLLYCACONITINE; NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; NICOTINIC RECEPTOR BLOCKING AGENT; NORADRENALIN; PRESYNAPTIC RECEPTOR; SEROTONIN; TETRODOTOXIN;

BRAIN REGION; CALCIUM CELL LEVEL; CENTRAL NERVOUS SYSTEM; CORPUS STRIATUM; DEPOLARIZATION; ELECTROPHYSIOLOGY; HIPPOCAMPUS; HUMAN; NERVE ENDING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SENSORY CORTEX; SYNAPTIC TRANSMISSION; THALAMUS;

ANIMALS; CELL COMMUNICATION; CENTRAL NERVOUS SYSTEM; HUMANS; NICOTINIC AGONISTS; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 0032759393     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(99)00016-8     Document Type: Review

References (160)

1. Agnati L.F., Zoli M., Stromberg I., Fuxe K. Intracellular communication in the brain: wiring versus volume transmission. Neuroscience. 69:1995;711-726.
2. Alkondon M., Pereira E.F.R., Wonnacott S., Albuquerque E.X. Blockade of nicotinic currents in hippocampal neurons defines methyllycaconitine as a potent and specific receptor antagonist. Mol. Pharmacol. 41:1992;802-808.
3. Alkondon M., Albuquerque E.X. Diversity of nicotine receptors in rat hippocampal neurons: I. Pharmacological and functional evidence for distinct structural subtypes. J. Pharmacol. Exp. Ther. 265:1993;1455-1473.
4. Alkondon M., Rocha E.S., Maelicke A., Albuquerque E.X. Diversity of nicotinic acetylcholine receptors in rat brain: V. α-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release. J. Pharmacol. Exp. Ther. 278:1996;1460-1471.
5. Alkondon M., Pereira E.F.R., Barbosa C.T.F., Albuquerque E.X. Neuronal nicotinic receptor activation modulates g-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J. Pharmacol. Exp. Ther. 283:1997;1396-1411.
6. Allen T.G.J., Brown D.A. Detection and modulation of acetylcholine release from neurites of rat basal forebrain cells in culture. J. Physiol. 492:1996;453-466.
7. Aramakis V.B., Metherate R. Nicotine selectively enhances NMDA receptor-mediated synaptic transmission during postnatal development in sensory neocortex. J. Neurosci. 18:1998;8485-8495.
8. 3H ]mecamylamine binding to rat brain membranes. Studies with mecamylamine and nicotine analogues Biochem. Pharmacol. 40:1990;2105-2110.
9. Bertolino M., Kellar K.J., Vicini S., Gillis R.A. Nicotinic receptor mediates spontaneous GABA release in the rat dorsal motor nucleus of the vagus. Neuroscience. 79:1997;671-681.
10. Bertrand D., Changeux J.-P. Nicotinic receptor: an allosteric protein specialized for intercellular communication. Neuroscience. 7:1995;75-90.
11. Bhat R.V., Turner S.L., Selvaag S.R., Marks M.J., Collins A.C. Regulation of brain nicotinic receptors by chronic agonist infusion. J. Neurochem. 56:1991;1932-1939.
12. Bordey A., Feltz P., Trouslard J. Nicotinic actions on neurons of the central autonomic area in rat spinal cord slices. J. Physiol. 497:1996;175-187.
13. Buisson B., Gopalakrishnan M., Arneric S.P., Sullivan J.P., Bertrand D. Human α4β2 neuronal nicotinic acetylcholine receptor in HEK 293 cells: a patch-clamp study. J. Neurosci. 16:1996;7880-7891.
14. Chéramy A., Godeheu G., L'Hirondel M., Glowinski J. Cooperative contribution of cholinergic and NMDA receptors in the presynaptic control of the dopamine release from synaptosomes of the rat striatum. J. Pharmacol. Exp. Ther. 276:1996;616-625.
15. 3H ]dopamine release Br. J. Pharmacol. 117:1996;595-606.
16. Coggan J.S., Paysan J., Conroy W.G., Berg D.K. Direct recording of nicotinic responses in presynaptic nerve terminals. J. Neurosci. 17:1997;5798-5806.
17. Cooper E., Coutrier S., Ballivet M. Pentameric structure and subunit stoichiometry of a neuronal nicotinic receptor. Nature. 350:1991;235-238.
18. Coutrier S., Bertrand D., Matter J.M., Hernandez M.C., Bertrand S., Millar N., Valera S., Barkas T., Ballivet M. A neuronal nicotinic acetylcholine receptor subunit (α7) is developmentally regulated and forms a homo-oligomeric channel blocked by α-BTX. Neuron. 5:1990;847-856.
19. Cromwell H.C., Levine M.S. Neocortical damage alters synaptic responses of neostriatal neurons in vivo. Neuroscience. 75:1996;361-372.
20. Dajas-Bailador F., Costa G., Dajas F., Emmett S. Effects of α-erabutoxin, α-bungarotoxin, α-cobratoxin and fasciculin on the nicotine-evoked release of dopamine in the rat striatum in vivo. Neurochem. Int. 33:1998;307-312.
21. 2+ levels in rat carotid body type I cells. J. Physiol. 498:1997;327-338.
22. Decker M.W., Majchzark M.J., Arneric S.P. Effects of lobeline, a nicotinic receptor agonist, on learning and memory. Pharmacol. Biochem. Behav. 45:1993;571-576.
23. Descarries L., Audet M.A., Donat G., Garcia S., Oleskevich S., Seguela P., Soghomonian J.J., Watkins K.C. Morphology of central serotonin neurons. Brief review of quantified aspects of their distribution and ultrastructural relationship. Ann. N.Y. Acad. Sci. 600:1990;81-82.
24. Descarries L., Gisiger V., Steriade M. Diffuse transmission by acetylcholine in the CNS. Prog. Neurobiol. 53:1997;603-625.
25. Descarries L., Watkins K.C., Lapierre Y. Noradrenergic axon terminals in the cerebral cortex of rat: III. Topometric ultrastructural analysis. Brain Res. 133:1977;197-222.
26. Didier M., Berman S.A., Lindstrom J., Bursztajn S. Characterization of nicotinic acetylcholine receptors expressed in primary cultures of cerebellar granule cells. Mol. Brain Res. 30:1995;17-28.
27. Dolezal V., Lee K., Schobert A., Hertting G. The influx and the release of norepinephrine evoked by stimulation of presynaptic nicotinic receptors of chick sympathetic neurons in culture are not mediated via L-, M-, or P-type calcium channels. Brain Res. 740:1996;75-80.
28. El-Bizri H., Clarke P.B.S. Blockade of nicotinic receptor-mediated release of dopamine from striatal synaptosomes by chlorisondamine administered in vivo. Br. J. Pharmacol. 111:1994;414-418.
29. Elgoyhen A.B., Johnson D.S., Boulter J., Vetter D.E., Heinemann S. α9: An acetylcholine receptor with novel pharmacological properties expressed in rat cochlear hair cells. Cell. 79:1994;705-715.
30. Fedele E., Varnier G., Ansaldo M.A., Raiteri M. Nicotine administration stimulates the in vivo N-methyl-D-aspartate receptor/nitric oxide/cyclic GMP pathway in rat hippocampus through glutamate release. Br. J. Pharmacol. 125:1998;1042-1048.
31. Frazier C.J., Rollins Y.D., Breese C.R., Leonard S., Freedman R., Dunwiddie T.V. Acetylcholine activates an alpha-bungarotoxin-sensitive nicotinic current in rat hippocampal interneurons, but not pyramidal cells. J. Neurosci. 18:1998;1187-1195.
32. Fryer J.D., Lukas R.J. Antidepressants noncompetetively inhibit nicotinic acetylcholine receptor function. J. Neurochem. 72:1999;1117-1124.
33. Freund T.F. GABAergic septal and serotonergic median raphe afferents preferentially innervate inhibitory interneurons in the hippocampus and dentate gyrus. Epilepsy Res., Suppl. 7:1992;79-91.
34. Freund T.F., Gulyas A.I., Acsady L., Gorcs T., Toth K. Serotonergic control of the hippocampus via local inhibitory interneurons. Proc. Natl. Acad. Sci. 87:1990;8501-8505.
35. Fu W.M., Liu J.J. Regulation of acetylcholine release by presynaptic nicotinic receptors at developing neuromuscular synapses. Mol. Pharmacol. 51:1997;390-398.
36. K. Fuxe, L.F. Agnati, Two principal modes of electrochemical communication in the brain: volume versus wiring transmission, in: K. Fuxe, L.F. Agnati (Eds.), Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission, Raven Press, New York, 1991, pp. 1-9.
37. Garcia-Colunga J., Awad J.N., Miledi R. Blockage of muscle and neuronal nicotinic acetylcholine receptors by fluoxetine (Prozac). Proc. Natl. Acad. Sci. U.S.A. 94:1997;2041-2044.
38. Gerzanich V., Anand R., Lindstrom J. Homomers of α8 and α7 subunits of nicotinic receptors exhibit similar channel but contrasting binding sites properties. Mol Pharmacol. 45:1994;212-220.
39. Giacobini E. Cholinesterase inhibitors for Alzheimer's disease therapy: from tacrine to future applications. Neurochem. Int. 32:1998;413-419.
40. Gopalakrishnan M., Molinari E.J., Sullivan J.P. Regulation of human α4β2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways. Mol. Pharmacol. 52:1997;524-534.
41. Gould J., Reeve H.L., Vaughan P.F., Peers C. Nicotinic acetylcholine receptors in human neuroblastoma (SH-SY5Y) cells. Neurosci. Lett. 45:1992;201-204.
42. 3H ]dopamine release from synaptosomes prepared from the mouse striatum J. Neurochem. 59:1992;848-856.
43. 3H ]dopamine release from mouse striatal synaptosomes and response to chronic L-nicotine treatment J. Pharmacol. Exp. Ther. 282:1997;32-43.
44. Gray R., Rajan A.S., Radcliffe K.A., Yakehiro M., Dani J.A. Hippocampal synaptic transmission enhanced by low concentration of nicotine. Nature. 383:1996;713-716.
45. Harvey S.C., McIntosh J.M., Cartier G.E., Maddox F.N., Luetje C.W. Determinants of specificity for α-conotoxin MII on α3β2 neuronal nicotinic receptors. Mol. Pharmacol. 51:1997;336-342.
46. Hennings E.C.P., Kiss J.P., Vizi E.S. Nicotinic acetylcholine receptor antagonist effect of fluoxetine in rat hippocampal slices. Brain Res. 759:1997;292-294.
47. Hennings E.C.P., Kiss J.P., De Oliveira K., Tóth P.T., Vizi E.S. Nicotinic acetylcholine receptor antagonistic activity of different monoamine uptake blockers in rat hippocampal slices. J. Neurochem. 73:1999;. in press.
48. Hjelde T., Mehl A., Schanke T.M., Fonnum F. Teratogenic effects of trichlorfon (Metrifonate) on the guinea-pig brain. Determination of the effective dose and the sensitive period. Neurochem. Int. 32:1998;469-477.
49. Hörtnagl H., Hellweg R. Insights into the role of the cholinergic component of the septohippocampal pathway: what have we learned from experimental lesion studies? Brain Res. Bull. 43:1997;245-255.
50. Hunter B.E., de Fiebre C.M., Papke R.L., Kem W.R., Meyer E.M. A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci. Lett. 168:1994;130-134.
51. Jones S., Yakel J.L. Functional nicotinic ACh receptors on interneurones in the rat hippocampus. J. Physiol. 504:1997;603-610.
52. Karczmar A. Anticholinesterases: dramatic aspects of their use and misuse. Neurochem. Int. 32:1998;401-411.
53. Karlin A. Structure of nicotinic acetylcholine receptors. Curr. Opin. Neurobiol. 3:1993;299-309.
54. Betz H. Homology and analogy in transmembrane channel design: lessons from synaptic membrane proteins. Biochemistry. 29:1990;3591-3599.
55. Kása P., Rakonczay Z., Gulya K. The cholinergic system in Alzheimer's disease. Prog. Neurobiol. 52:1997;511-535.
56. Ke L., Eisenhow C.M., Bencherif M., Lukas R.J. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes: 1. Dose- and time-dependent effects of nicotine treatment. J. Pharmacol. Exp. Ther. 286:1998;825-840.
57. Kiss J.P., Sershen H., Lajtha A., Vizi E.S. Inhibition of neuronal nitric oxide synthase potentiates the dimethylphenylpiperazinium-evoked carrier-mediated release of noradrenaline from rat hippocampal slices. Neurosci. Lett. 215:1996;115-118.
58. Kiss J.P., Windisch K., Balla A., Sershen H., Lajtha A. Dual effect of DMPP on the resting release of noradrenaline from rat hippocampal slices. Brain Res. Bull. 43:1997;254-262.
59. Kiss J.P., Vizi E.S., Westerink B.H.C. Effect of neostigmine on the hippocampal noradrenaline release: role of cholinergic receptors. NeuroReport. 10:1999;81-86.
60. Khan I.M., Yaksh T.L., Taylor P. Epibatidine binding sites and activity in the spinal cord. Brain Res. 753:1997;369-382.
61. Kulak J.M., Nguyen T.A., Olivera B.M., McIntosh J.M. α-Conotoxin MII blocks nicotine-stimulated dopamine release in rat striatal synaptosomes. J. Neurosci. 17:1997;5263-5270.
62. Landwehrmeyer G.B., Standaert D.G., Testa C.M., Penney J.B. Jr., Young A.B. NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15:1995;5297-5307.
63. Le Jeune H., Aubert I., Jourdan F., Quirion R. Developmental profiles of various cholinergic markers in the rat main olfactory bulb using quantitative autoradiography. J. Comp. Neurol. 373:1996;433-450.
64. Lee E.H., Ma Y.L. Amphetamine enhances memory retention and facilities norepinephrine release from the hippocampus in rats. Brain Res. Bull. 37:1995;411-416.
65. Lena C., Changeux J.-P., Mulle C. Evidence for preterminal nicotine receptors on GABAergic axons in the rat interpeduncular nucleus. J. Neurosci. 13:1993;2680-2688.
66. 2+ ions in nicotinic facilitation of GABA release in mouse thalamus. J. Neurosci. 17:1997;576-585.
67. 3H ]5-HT from rat hippocampal slices Neuropharmacology. 35:1996;1769-1777.
68. Levin E.D., Torry D., Christopher N.C., Yu X., Einstein G., Schwartz-Bloom R.D. Is binding to nicotinic acetylcholine and dopamine receptors related to working memory in rats? Brain Res. Bull. 43:1997;295-304.
69. Liang S.D., Vizi E.S. Positive feedback modulation of acetylcholine release from isolated superior cervical ganglion. J. Pharmacol. Exp. Ther. 280:1997;650-655.
70. J. Lindstrom, Nicotinic acetylcholine receptors, in: R.A. North (Ed.), Handbook of Receptors and Channels, CRC Press, 1995, pp. 153-175.
71. 3H -nicotine to a single class of high affinity sites in rat brain membrane Mol. Pharmacol. 29:1986;448-454.
72. Lopez M.G., Fonteriz R.I., Gandia L., de la Fuente M., Villarroya M., Garcia-Sancho J., Garcia A.G. The nicotinic acetylcholine receptor of bovine chromaffin cell, a new target for dihydropyridines. Eur. J. Pharmacol. 247:1993;199-207.
73. Lu Y., Grady S., Marks M.J., Picciotto M., Changeux J.P., Collins A.C. Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J. Pharmacol. Exp. Ther. 287:1998;648-657.
74. Luetje C.W., Wada K., Rogers S., Abramson S.N., Tsuji K., Ileinemann S., Patrick J. Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. J. Neurochem. 55:1990;632-640.
75. Lukas R.J. Detection of low affinity α-bungarotoxin binding sites in the rat central neurons system. Biochemistry. 23:1984;1160-1164.
76. Lukas R.J. Diversity and patterns of regulation of nicotinic receptor subtypes. Ann. N.Y. Acad. Sci. 757:1995;153-168.
77. Lukas R.J., Bencherif M. Heterogeneity and regulation of nicotinic acetylcholine receptors. Int. Rev. Neurobiol. 34:1992;25-131.
78. Lukas R.J., Bennett E.L. Interaction of nicotinic receptor affinity reagents with central neurons system α-bungarotoxin binding entities. Mol. Pharmacol. 17:1980;149-155.
79. Luo S., Kulak J.M., Cartier G.E., Jacobsen R.B., Yoshikami D., Olivera B.M., McIntosh J.M. Alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release. J. Neurosci. 18:1998;8571-8579.
80. Marchi M., Raiteri M. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of impaired cholinergic function. J. Neurochem. 67:1996;1974-1981.
81. Marshall D.L., Soliakov L., Redfern P.H., Wonnacott S. Tetrodotoxin-sensitivity of nicotine-induced dopamine release from rat striatum. Neuropharmacology. 35:1996;1531-1536.
82. Marshall D.L., Redfern P.H., Wonnacott S. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and nicotine-treated rats. J. Neurochem. 68:1997;1511-1519.
83. McGehee D.S., Heath M.J.S., Gelber S., Devay P., Role L.W. Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors. Science. 269:1995;1692-1696.
84. Milusheva E.A., Dóda M., Pasztor E., Lajtha A., Sershen H., Vizi E.S. Regulatory interactions among axon terminals affecting the release of different transmitters from rat striatal slices under hypoxic and hypoglycemic conditions. J. Neurochem. 59:1992;946-952.
85. Milusheva E.A., Baranyi M., Zelles T., Mike Á., Vizi E.S. Release of acetylcholine and noradrenaline from the cholinergic and adrenergic afferents in rat hippocampal CA1, CA3 and dentate gyrus regions. Eur. J. Neurosci. 6:1994;187-192.
86. 3H ]dopamine in rat striatal slices Neurochem. Int. 28:1996;501-507.
87. Mulder A.H., Wardeh G., Hogenboom F., Frankhuyzen A.L. κ and δ opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature. 308:1984;278-282.
88. Mulle C., Choquet D., Korn H., Changeux J.P. Calcium influx through nicotinic receptor in central neurons: its relevance to cellular regulation. Neuron. 8:1992;135-143.
89. Oleskevich S., Descarries L., Lacaille J.-C. Qualified distribution of the noradrenaline innervation in the hippocampus of adult rat. J. Neurosci. 9:1989;3803-3815.
90. Oleskevich S., Descarries L., Watkins K.C., Seguela P., Daszuta A. Ultrastructural features of the serotonin innervation in adult rat hippocampus: an immunocytochemical description in single and serial thin sections. Neuroscience. 42:1991;777-791.
91. Parker M.J., Beck A., Luetje C.W. Neuronal nicotinic receptor β2 and β4 subunits confer large differences in agonist binding affinity. Mol. Pharmacol. 54:1998;1132-1139.
92. Paton W.D.M., Zaimis E.J. The pharmacological actions of polymethylene bistrimethylammonium salts. Br. J. Pharmacol. 4:1949;381-400.
93. Patrick J., Sequela P., Vernino S., Amador M., Luetje C.W., Dani J.A. Functional diversity of neuronal nicotinic acetylcholine receptors. Prog. Brain Res. 98:1993;113-120.
94. Pidoplichko V.I., DeBiasi M., Williams J.T., Dani J.A. Nicotine activates and desensitizes midbrain dopamine neurons. Nature. 390:1997;401-404.
95. Potter P.E., Thorne B., Gaughan C. Modulation of hippocampal norepinephrine release by cholinergic agonists is altered by AF64A lesion. Brain Res. Bull. 42:1997;153-160.
96. Qian C., Li T., Shen T.Y., Libertine-Garahan L., Eckman J., Biftu T., Ip S. Epibatidine is a nicotinic analgesic. Eur. J. Pharmacol. 250:1993;R13-R14.
97. Rao T.S., Correa L.D., Lloyd G.K. Effects of lobeline and dimethylphenylpiperazinium iodide (DMPP) on N-methyl-D-aspartate (NMDA)-evoked acetylcholine release in vitro: evidence for a lack of involvement of classical neuronal nicotinic receptors. Neuropharmacology. 36:1997;39-50.
98. 3H ]dopamine release from striatal synaptosomes: pharmacological characterization J. Neurochem. 54:1990;937-945.
99. Reavill C., Walther B., Stolerman I.P., Testa B. Behavioral and pharmacokinetics studies on nicotine, cytosine and lobeline. Neuropharmacology. 29:1990;619-624.
100. Reece L.J., Schwartzkroin P.A. Nicotine exerts differential effects on different CA1 hippocampal cell types. Brain Res. 540:1991;287-290.
101. Reece L.J., Schwartzkroin P.A. Effects of cholinergic agonists on two non-pyramidal cell types in rat hippocampal slices. Brain Res. 566:1991;115-126.
102. Revah F., Bertrand D., Gaizi J-L., Devillers-Thiery A., Mulle C., Hussy N., Bertrand S., Ballivet M., Changeux J.-P. Mutations in the channel domain alter desensitization of a neuronal nicotinic receptor. Nature. 353:1991;846-849.
103. Ridley R.M., Baker H.-F., Harder J.A., Pearson C. Effects of lesions of different parts of the septo-hippocampal system in primates on learning and retention of information acquired before or after surgery. Brain Res. Bull. 40:1996;21-32.
104. Role L.W., Berg D.K. Nicotinic receptors in the development and modulation of CNS synapses. Neuron. 16:1996;1077-1085.
105. Rovira C., Ben-Ari Y., Cherubini E., Krnjevic K., Ropert N. Pharmacology of the dendritic action of acetylcholine and further observations on the somatic disinhibition in the rat hippocampus in situ. Neuroscience. 8:1983;97-106.
106. Rowell P.P., Li M. Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. J. Neurochem. 68:1997;1982-1989.
107. Sacaan A.I., Dunlop J.L., Lloyd G.R. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices. J. Pharmacol. Exp. Ther. 274:1995;224-230.
108. Sacaan A.I., Reid R.T., Santori E.M., Adams P., Correa L.D., Mahaffy L.S., Bleicher L., Cosford N.D., Stauderman K.A., McDonald I.A., Rao T.S., Lloyd G.R. Pharmacological characterization of SIB-1765F: a novel cholinergic ion channel agonist. J. Pharmacol. Exp. Ther. 280:1997;373-383.
109. Salin-Pascual R.J., Drucker-Colin R. A novel effect of nicotine on mood and sleep in major depression. NeuroReport. 9:1998;57-60.
110. Sandor N.T., Zelles T., Kiss J.P., Sershen H., Torocsik A., Lajtha A., Vizi E.S. Effect of nicotine on dopaminergic-cholinergic interaction in the striatum. Brain Res. 567:1991;313-316.
111. Sandor N.T., Kiss J.P., Lendvai B., Sandor A., Vizi E.S. Naloxone enhanced the release of acetylcholine from cholinergic interneurons of the striatum if the dopaminergic input is impaired. Brain Res. 552:1991;343-345.
112. Schilström B., Nomikos G.G., Nisell M., Hertel P., Svensson T.H. N-Methyl-D-aspartate receptor antagonism in the ventral tegmental area diminishes the systemic nicotine-induced dopamine release in the nucleus accumbens. Neuroscience. 82:1998;781-789.
113. H. Schröder, A. Weivers, Ch. Birtsch, M. Ghobrial, E. Giacobini, A. Maelicke, in: E. Giacobini, R.E. Becker (Eds.), Alzheimer's Disease, Boston, 1995, pp. 181-185.
114. Schulz D.W., Zigmond R.E. Neuronal bungarotoxin blocks the nicotinic stimulation of endogenous dopamine release from rat striatum. Neurosci. Lett. 98:1989;310-316.
115. 125I -neuronal bungarotoxin J. Neurosci. 11:1991;287-297.
116. Seguela P., Wadiche J., Dineley-Miller K., Patrick J.W. Molecular cloning, functional properties, and distribution of rat brain α7: a nicotinic cation channel highly permeable to calcium. J. Neurosci. 13:1993;596-604.
117. Sershen H., Balla A., Lajtha A., Vizi E.S. Characterization of nicotinic receptors involved in the release of norepinephrine from hippocampus. Neuroscience. 77:1997;121-130.
118. Sivilotti L.G., Colquhoun D. Acetylcholine receptors: too many channels, too few functions. Science. 269:1995;1681-1682.
119. Sivilotti L.G., McNeil D.K., Lewis T.M., Nassar M.A., Schoepfer R., Colquhoun D. Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single-channel behaviour. J. Physiol. (London). 500:1997;123-138.
120. 3H dopamine release from rat striatal synaptosomes J. Neurochem. 67:1996;163-170.
121. Somogyi G.T., Vizi E.S. Evidence that cholinergic axon terminals are equipped with both muscarinic and adenosine receptors. Brain Res. Bull. 21:1988;575-579.
122. Sziraki I., Sershen H., Benuck M., Hashim A., Lajtha A. Receptor systems participating in nicotine-specific effects. Neurochem. Int. 33:1998;445-457.
123. Takahashi T., Tsunoda Y., Lu Y., Wiley J., Owyang C. Nicotinic receptor evoked release of acetylcholine and somatostatin in the myenteric plexus is coupled to calcium influx via N-type calcium channels. J. Pharmacol. Exp. Ther. 263:1992;1-5.
124. Tani Y., Saito K., Imoto M., Ohno T. Pharmacological characterization of nicotinic receptor-mediated acetylcholine release in rat brain - an in vivo microdialysis study. Eur. J. Pharmacol. 351:1998;181-188.
125. 3H ]dopamine J. Pharmacol. Exp. Ther. 283:1997;778-787.
126. 3H ]dopamine uptake J. Pharmacol. Exp. Ther. 280:1997;1432-1444.
127. Thomas P., Stephens M., Wilkie G., Amar M., Lunt G.G., Whiting P., Gallagher T., Pereira E., Alkondon M., Albuquerque E.X., Wonnacott S. (+)-Anatoxin-a is a potent agonist at the neuronal nicotinic acetylcholine receptors. J. Neurochem. 60:1993;2308-2311.
128. Todorov L., Windisch K., Sershen H., Lajtha A., Papasova M., Vizi E.S. Prejunctional nicotinic receptors involved in facilitation of stimulation-evoked norepinephrine release from vas deferens of the guinea-pig. Br. J. Pharmacol. 102:1991;186-190.
129. Toth E., Sershen H., Hashim A., Vizi E.S., Lajtha A. Effect of nicotine on extracellular levels of neurotransmitters assessed by microdialysis in various brain regions: role of glutamic acid. Neurochem. Res. 17:1992;265-271.
130. Toth E., Vizi E.S., Lajtha A. Effect of nicotine on the levels of extracellular amino acids in regions of the rat brain in vivo. Neuropharmacology. 32:1993;827-832.
131. Törõcsik A., Oberfrank F., Sershen H., Lajtha A., Nemessy K., Vizi E.S. Characterization of somatodendritic neuronal nicotinic receptors located in the myenteric plexus. Eur. J. Pharmacol. 202:1991;297-302.
132. Ullian E.M., Sargent P.B. Pronounced cellular diversity and extrasynaptic location of nicotinic acetylcholine receptor subunit immunoreactivities in the chicken pretectum. J. Neurosci. 15:1995;7012-7023.
133. Umbriaco D., Garcia S., Beaulieu C., Descarries L. Relational features of acetylcholine, noradrenaline, serotonin and GABA axon terminals in the stratum radiatum of adult rat hippocampus (CA1). Hippocampus. 5:1995;605-620.
134. Vernino S., Amador M., Luetje C.W., Patrick J., Dani J.A. Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors. Neuron. 8:1992;127-134.
135. Vidal C., Changeux J.-P. Neuronal nicotinic acetylcholine receptors in the brain. News Physiol. Sci. 11:1996;202-208.
136. Vizi E.S., Hársing L.G. Jr., Knoll J. Presynaptic inhibition leading to disinhibition of acetylcholine release from interneurons of the caudate nucleus: effects of dopamine, beta-endorphin and D-Alfa2-Pro5 enkephalinamide. Neuroscience. 2:1977;953-961.
137. Vizi E.S. Presynaptic modulation of neurochemical transmission. Prog. Neurobiol. 12:1979;181-290.
138. E.S. Vizi, Nonsynaptic modulation of transmitter release: pharmacological implication, TIPS (1980) 172-175.
139. E.S. Vizi, Nonsynaptic Interactions Between Neurons: Modulation of Neurochemical Transmission. Pharmacological and Clinical Aspects, Wiley, Chichester, 1984.
140. Vizi E.S., Hársing L.G. Jr., Zimanyi I., Gaal G. Release and turnover of noradrenaline in isolated median eminence: lack of negative feedback modulation. Neuroscience. 16:1985;907-916.
141. Vizi E.S., Somogyi G.T., Nagashima H., Duncalf D., Chaudhry I.A., Kobayashi O., Foldes F.F. Tubocurarine and pancuronium inhibit evoked release of acetylcholine from the mouse hemidiaphraghm preparations. Br. J. Anaesth. 59:1987;226-231.
142. Vizi E.S., Lábos E. Nonsynaptic interactions at presynaptic level. Prog. Neurobiol. 37:1991;145-163.
143. Vizi E.S., Sershen H., Balla A., Mike A., Windish K., Juranyi Zs., Lajtha A. Neurochemical evidence of heterogeneity of presynaptic and somatodendritic nicotinic acetylcholine receptors. Ann. N.Y. Acad. Sci. 757:1995;84-99.
144. Vizi E.S., Lendvai B. Side effects of nondepolarizing muscle relaxants: relationship to their antinicotinic and antimuscarinic actions. Pharmacol. Ther. 73:1997;75-89.
145. Vizi E.S. Different temperature dependence of carrier-mediated (cytoplasmic) and stimulus-evoked (exocytotic) release of transmitter: a simple method to separate the two types of release. Neurochem. Int. 33:1998;359-366.
146. Vizi E.S., Kiss J.P. Neurochemistry and pharmacology of the major hippocampal transmitter systems: synaptic and nonsynaptic interactions. Hippocampus. 8:1998;566-607.
147. Wada K., Ballivet M., Boulter J., Connoly J., Wada E., Deneris E.S., Swanson L.W., Heinemann S., Patrick J. Functional expression of a new pharmacological subtype of brain nicotinic acetylcholine receptor. Science. 240:1988;330-334.
148. 3H ]noradrenaline release evoked by nicotinic receptor activation from the human neuroblastoma SH-SY5Y J. Neurochem. 71:1998;1482-1489.
149. 3H ]choline by the rat phrenic nerve-hemidiaphragm preparation Naunyn-Schmiedeberg's Arch. Pharmacol. 335:1987;231-237.
150. Wilkie G.I., Hutson P., Sullivan J.P., Wonnacott S. Pharmacological characterization of a nicotinic autoreceptor in rat hippocampal synaptosomes. Neurochem. Res. 21:1996;1141-1148.
151. Whiting P., Lindstrom J. Purification and characterization of a nicotinic acetylcholine receptor from rat brain. Proc. Natl. Acad. Sci. U.S.A. 84:1987;595-599.
152. Wonnacott S., Irons J., Rapier C., Thorne B., Lunt G.G. Presynaptic modulation of transmitter release by nicotinic receptors. Prog. Brain Res. 79:1989;157-163.
153. S. Wonnacott, A. Drasdo, E. Sanderson, P. Rowell, Presynaptic nicotinic receptors and modulation of transmitter release, in: G. Bock, J. Marsch (Eds.), The Biology of Nicotine Dependence, Wiley, Chichester, 1990, pp. 87-101.
154. S. Wonnacott, Modulation of neurotransmitter release by some therapeutic and socially used drugs: nicotine, in: Powis, Bunn (Eds.), Neurotransmitter Release and its Modulation, Cambridge Univ. Press, 1995.
155. Wonnacott S. Presynaptic nicotinic ACh receptors. TINS. 20:1997;92-98.
156. Yang X., Criswell H.E., Breese G.R. Nicotine-induced inhibition in medial septum involves activation of presynaptic nicotinic cholinergic receptors on gamma-aminobutyric acid-containing neurons. J. Pharmacol. Exp. Ther. 276:1996;482-489.
157. Zhang X., Gong Z.H., Fasth K.J., Langstrom B., Nordberg A. Interaction of the nicotinic agonist (R,S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex. Neurochem. Int. 32:1998;435-441.
158. Zoli M., Le Novére N., Hill J.A. Jr., Changeux J.-P. Developmental regulation of nicotinic ACh receptor subunit mRNAs in the rat central and peripheral nervous systems. J. Neurosci. 15:1995;1912-1939.
159. Zorumski C.F., Thio L.L., Isenberg K.E., Clifford D.B. Nicotinic acetylcholine currents in cultured postnatal rat hippocampal neurons. Mol. Pharmacol. 41:1992;931-936.
160. Zwart R., Oortgiesen M., Vijverberg H.K. Differential modulation of α3β2 and α3β4 neuronal nicotinic receptors expressed in Xenopus oocytes by flufenamic acid and niflumic acid. J. Neurosci. 15:1995;2168-2178.